Author

Megha Raghunathan

San Diego State UniversityORCID 0000-0002-9330-7639Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:proteomics· 1

Frequent Co-Authors

Elena OropezaiD· 2 shared Jerry Tyler DeWittiD· 2 shared Matthew Neil BainbridgeiD· 2 shared Svasti HaricharaniD· 2 shared Alberto ConcardiiD· 1 shared Aloran Mazumder· 1 shared Asona J. LuiiD· 1 shared Astha LamichhaneiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Elena OropezaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The impact of patient biology on racial disparities in breast cancer outcome

Jerry Tyler DeWitt, D Jimenez-Tovar, Elena Oropeza, ET Karabay, Casandra Nguyen, Astha Lamichhane, Megha Raghunathan, Blake Gabel, Badri Narayanan Narasimhan, Fenna Candy, Lindsey Kuwahara, Audrey G Head, Serge Batalov, Erin L. Kirk, Somaye Zare, , Svasti Haricharan

This study identifies molecular differences in HR+ breast cancer between Black and White women, linking structural factors like poverty to tumor biology and immune signatures.

Cancer Research · Oct 26, 2026Peer-reviewedCancer Biology

Aberrant cytoplasmic localization of MLH1 characterizes a sub-clonal breast cancer cell population that seeds recurrence

Aloran Mazumder, Jerry Tyler DeWitt, Elena Oropeza, Nindo B. Punturi, Daniel Lozano, Megha Raghunathan, Jonathan M. Piscitelli, Elham Sajjadi, Elena Guerini-Rocco, Konstantinos Venetis, Mariia D. Ivanova, Eltjona Mane, Marianna D’Ercole, Alberto Concardi, Nicola Fusco, , Svasti Haricharan

This study identifies aberrant cytoplasmic MLH1 localization in sub-clonal breast cancer cells as a driver of endocrine resistance, showing it predicts response to CDK4/6 inhibitors.

Nature Communications · Dec 10, 2025Peer-reviewedCancer Biology